These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 28814510)

  • 1. A Heterologous Model of Thrombospondin Type 1 Domain-Containing 7A-Associated Membranous Nephropathy.
    Tomas NM; Meyer-Schwesinger C; von Spiegel H; Kotb AM; Zahner G; Hoxha E; Helmchen U; Endlich N; Koch-Nolte F; Stahl RAK
    J Am Soc Nephrol; 2017 Nov; 28(11):3262-3277. PubMed ID: 28814510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy.
    Tomas NM; Hoxha E; Reinicke AT; Fester L; Helmchen U; Gerth J; Bachmann F; Budde K; Koch-Nolte F; Zahner G; Rune G; Lambeau G; Meyer-Schwesinger C; Stahl RA
    J Clin Invest; 2016 Jul; 126(7):2519-32. PubMed ID: 27214550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Most N-Terminal Region of THSD7A Is the Predominant Target for Autoimmunity in THSD7A-Associated Membranous Nephropathy.
    Seifert L; Hoxha E; Eichhoff AM; Zahner G; Dehde S; Reinhard L; Koch-Nolte F; Stahl RAK; Tomas NM
    J Am Soc Nephrol; 2018 May; 29(5):1536-1548. PubMed ID: 29555830
    [No Abstract]   [Full Text] [Related]  

  • 4. Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy.
    Wang J; Cui Z; Lu J; Probst C; Zhang YM; Wang X; Qu Z; Wang F; Meng LQ; Cheng XY; Liu G; Debiec H; Ronco P; Zhao MH
    Clin J Am Soc Nephrol; 2017 Oct; 12(10):1642-1651. PubMed ID: 28801527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human anti-thrombospondin type 1 domain-containing 7A antibodies induce membranous nephropathy through activation of lectin complement pathway.
    Wang Z; Wen L; Dou Y; Zhao Z
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29769410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-Specific IgG Subclasses in Primary and Malignancy-Associated Membranous Nephropathy.
    von Haxthausen F; Reinhard L; Pinnschmidt HO; Rink M; Soave A; Hoxha E; Stahl RAK
    Front Immunol; 2018; 9():3035. PubMed ID: 30619370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Membranous Nephropathy in Patients With THSD7A Antibodies Using Immunoadsorption.
    Weinmann-Menke J; Holtz S; Sollinger D; Dörken M; Boedecker S; Schamberger B; Pfister F; Amann K; Lutz J
    Am J Kidney Dis; 2019 Dec; 74(6):849-852. PubMed ID: 31451329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain-Containing 7A-Specific Antibodies in Membranous Nephropathy.
    Hoxha E; Beck LH; Wiech T; Tomas NM; Probst C; Mindorf S; Meyer-Schwesinger C; Zahner G; Stahl PR; Schöpper R; Panzer U; Harendza S; Helmchen U; Salant DJ; Stahl RA
    J Am Soc Nephrol; 2017 Feb; 28(2):520-531. PubMed ID: 27436855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombospondin Type 1 Domain-Containing 7A Localizes to the Slit Diaphragm and Stabilizes Membrane Dynamics of Fully Differentiated Podocytes.
    Herwig J; Skuza S; Sachs W; Sachs M; Failla AV; Rune G; Meyer TN; Fester L; Meyer-Schwesinger C
    J Am Soc Nephrol; 2019 May; 30(5):824-839. PubMed ID: 30971456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of THSD7A-antibodies not binding to glomerular THSD7A in a patient with diabetes mellitus but no membranous nephropathy.
    Reinhard L; Thomas C; Machalitza M; Lattwein E; Weiss LS; Vitu J; Wiech T; Stahl RAK; Hoxha E
    Sci Rep; 2021 Aug; 11(1):16188. PubMed ID: 34376704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombospondin type-1 domain-containing 7A-associated membranous nephropathy after resection of rectal cancer: a case report.
    Taguchi S; Koshikawa Y; Ohyama S; Miyachi H; Ozawa H; Asada H
    BMC Nephrol; 2019 Feb; 20(1):43. PubMed ID: 30727973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of the determination of antibodies to thrombospondin type 1 containing domain 7A (THSD7A) in membranous nephropathy].
    Kakhsurueva PA; Kamyshova ES; Bobkova IN; Stavrovskaya EV; Rudenko TE; Andreeva EY
    Ter Arkh; 2023 Aug; 95(6):462-467. PubMed ID: 38158964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
    Tomas NM; Beck LH; Meyer-Schwesinger C; Seitz-Polski B; Ma H; Zahner G; Dolla G; Hoxha E; Helmchen U; Dabert-Gay AS; Debayle D; Merchant M; Klein J; Salant DJ; Stahl RAK; Lambeau G
    N Engl J Med; 2014 Dec; 371(24):2277-2287. PubMed ID: 25394321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Alternative Pathway Is Necessary and Sufficient for Complement Activation by Anti-THSD7A Autoantibodies, Which Are Predominantly IgG4 in Membranous Nephropathy.
    Manral P; Caza TN; Storey AJ; Beck LH; Borza DB
    Front Immunol; 2022; 13():952235. PubMed ID: 35874690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Features of phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in malignancy-associated membranous nephropathy.
    Zhang C; Zhang M; Chen D; Ren Q; Xu W; Zeng C; Qin W; Liu Z
    J Clin Pathol; 2019 Oct; 72(10):705-711. PubMed ID: 31243053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological characteristics of thrombospondin type 1 domain-containing 7A-associated membranous nephropathy.
    Hara S; Tsuji T; Fukasawa Y; Hisano S; Morito S; Hyodo T; Goto S; Nishi S; Yoshimoto A; Itoh T
    Virchows Arch; 2019 Jun; 474(6):735-743. PubMed ID: 30868298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Insight into the Role of PLA2R and THSD7A in Membranous Nephropathy.
    Zhang P; Huang W; Zheng Q; Tang J; Dong Z; Jiang Y; Liu Y; Liu W
    J Immunol Res; 2021; 2021():8163298. PubMed ID: 34337081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China.
    Zhang D; Zou J; Zhang C; Zhang W; Lin F; Jiang G
    Med Sci Monit; 2018 Jul; 24():5076-5083. PubMed ID: 30032157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membranous nephropathy associated with thrombospondin type-1 domain-containing 7A (THSD7A) in an adult woman with eosinophilia.
    Shirai S; Akiyama S; Kamijo-Ikemori A; Suzuki T; Ichikawa D; Koike J; Kimura K; Shibagaki Y
    CEN Case Rep; 2020 Feb; 9(1):65-73. PubMed ID: 31705303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of M
    Gong Z; Yuan S; Zhu X; Wang Y; Yu F; Yang D; Xu X; Liu H; Li J; Sun L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 45(6):693-700. PubMed ID: 32879127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.